Eagle Pharmaceuticals Inc (NASDAQ:EGRX)

Delayed Data
As of 4:00pm ET
 -0.18 / -0.45%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Eagle Pharmaceuticals Inc have a median target of 46.00, with a high estimate of 57.00 and a low estimate of 45.00. The median estimate represents a +16.25% increase from the last price of 39.57.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Eagle Pharmaceuticals Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -50.44%
Growthannually -16.19%


Growthquarterly 12.13%
Growthannually -1.43%
Key to the earnings and sales forecast charts.